MRNA

Moderna
D

MRNA

39.360
USD
-0.20
(-0.51%)
مغلق
حجم التداول
444,718
الربح لكل سهم
-11
العائد الربحي
-
P/E
-7
حجم السوق
15,146,429,041
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
التوصيات
    Abdilatif
    Abdilatif
    منذ 10 أشهر
    sell
    MRNA
    MRNA@101.02
    2024-02-01 09:45
    MRNA@101.02 Chart
    الربح
    357.00
    Abdilatif
    Abdilatif
    منذ 10 أشهر
    sell
    MRNA
    MRNA@101.83
    2024-01-29 10:09
    MRNA@101.83 Chart
    الربح
    -175.00
    المزيد
الأفكار والتحليلات
    هشام منسي
    هشام منسي
    منذ شهرين
    neutral
    MRNA
    MRNA
    2024-10-01 09:30
    MRNA Chart
    المزيد
أصول ذات صلة
    ABBV
    ABBV
    4.190
    (2.44%)
    175.700 USD
    AZN
    AZN
    0.950
    (1.47%)
    65.370 USD
    BMY
    BMY
    0.990
    (1.76%)
    57.280 USD
    BNTX
    BNTX
    1.810
    (1.63%)
    113.050 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    JNJ
    JNJ
    0.890
    (0.62%)
    144.450 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    المزيد
الأخبار

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.